Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of KL280006 injection for postoperative analgesia after pelvic/abdominal laparoscopy
CTR20201371Phase 2Completed
- Sponsor
- Sichuan Kelun-Biotech Biopharmaceutical
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of KL280006 in acute pain, postoperative pain, sponsored by Sichuan Kelun-Biotech Biopharmaceutical. Started Jul 2020; status: completed.
02
Drugs
KL280006
03
Conditions
acute painpostoperative pain
Beyond the preview
Go deeper on CTR20201371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201371.